These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2096481)

  • 21. [Estrogen replacement therapy: for whom, why and how?].
    Rozenberg S; Neusy S; Barudy J; Fellemans C; Jahjah L
    Rev Med Brux; 2002 Sep; 23(4):A382-9. PubMed ID: 12422465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone replacement therapy in the climacteric: benefits beyond sexuality.
    Maia H; Casoy J; Valente J
    Gynecol Endocrinol; 2009 Jan; 25(1):12-20. PubMed ID: 19165658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gradual discontinuation of hormone therapy does not prevent the reappearance of climacteric symptoms: a randomized prospective study.
    Haimov-Kochman R; Barak-Glantz E; Arbel R; Leefsma M; Brzezinski A; Milwidsky A; Hochner-Celnikier D
    Menopause; 2006; 13(3):370-6. PubMed ID: 16735933
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of hormone replacement therapy during menopause in the cardiovascular prevention].
    Turpin G
    Ann Cardiol Angeiol (Paris); 1994 Mar; 43(3):177-80. PubMed ID: 8024230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
    Savoca S; D'Agosta S; Lombardo G
    Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menopause and estrogen replacement therapy.
    Stuenkel CA
    Psychiatr Clin North Am; 1989 Mar; 12(1):133-52. PubMed ID: 2652104
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
    Döring GK
    Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Estrogen substitution in the postmenopause--effect and compliance].
    Dören M
    Ther Umsch; 1994 Nov; 51(11):767-72. PubMed ID: 7839335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimizing the dose of hormone replacement therapy.
    Rice VM
    Int J Fertil Womens Med; 2002; 47(5):205-10. PubMed ID: 12469707
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic concepts in the treatment of postmenopausal osteoporosis].
    Leidig-Bruckner G; Ziegler R
    Ther Umsch; 1994 Nov; 51(11):737-47. PubMed ID: 7839332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen replacement therapy and the estraderm transdermal system.
    Youngkin EQ
    Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HRT dosing regimens: continuous versus cyclic-pros and cons.
    Shoupe D
    Int J Fertil Womens Med; 2001; 46(1):7-15. PubMed ID: 11294619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic considerations in the management of the climacteric. A critical analysis of prevalent treatments.
    Upton GV
    J Reprod Med; 1984 Feb; 29(2):71-80. PubMed ID: 6368816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Peroral treatment with natural human estrogens in the climacteric].
    Sele V; Obel E
    Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Osteoporosis: prevention with postmenopausal hormonal substitution].
    Welti H
    Rev Med Suisse Romande; 1990 Jun; 110(6):565-9. PubMed ID: 2367794
    [No Abstract]   [Full Text] [Related]  

  • 38. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Recent evidence of estrogen therapy for osteoporosis].
    Higuchi T; Mizunuma H
    Clin Calcium; 2008 Aug; 18(8):1141-6. PubMed ID: 18677052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE
    Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen replacement therapy.
    Judd HL; Cleary RE; Creasman WT; Figge DC; Kase N; Rosenwaks Z; Tagatz GE
    Obstet Gynecol; 1981 Sep; 58(3):267-75. PubMed ID: 7022279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.